• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Clinical Trials

Posted inClinical Trials, COVID-19, Infections

WHO: Convalescent Plasma Is Useless in Treating COVID-19

by Nik Resovski and Timur Burkhanayev December 7, 2021September 8, 2022

Convalescent plasma does not improve patient survival and does not reduce the need in mechanical ventilation.

obesity
Posted inClinical Trials, Metabolism

Wegovy: Impressive Success of Semaglutide for Weight Loss

by Mark Gubar December 7, 2021September 8, 2022

Novo Nordisk’s newest drug did well in treating obesity and overweight.

Posted inClinical Trials, Rare/Orphan Diseases

Vyjuvek: Effective Treatment for Dystrophic Epidermolysis Bullosa

by Tanya von Reuss November 30, 2021September 8, 2022

Krystal Biotech’s beremagene geperpavec gene therapy will save from imminent death.

Posted inAutoimmune Diseases, Clinical Trials, Metabolism

Precigen ActoBio: Innovative Treatment for Type 1 Diabetes Mellitus

by Mark Gubar June 11, 2021September 8, 2022

The autoimmune disease will be defeated by restoring immune tolerance.

Posted inClinical Trials, Neuroscience

Masitinib for Alzheimer’s Disease: It Did Work!

by Mark Gubar and Julia Mardi April 12, 2021September 8, 2022

Masitinib by AB Science has curbed cognitive deterioration in Alzheimer-type dementia. And that’s a new hope.

Posted inClinical Trials, Oncology

Bemarituzumab: Breakthrough in Gastric Cancer Treatment

by Julia Mardi and Alex Avisoni April 7, 2021September 8, 2022

A new and effective targeted therapy, being developed by Five Prime Therapeutics and Amgen, for a deadly cancer disease in the past decade.

Brain.
Posted inClinical Trials, Neuroscience

Donanemab: Possible Treatment for Alzheimer’s Disease

by Tanya von Reuss April 5, 2021September 8, 2022

The amyloid hypothesis, being verified by Eli Lilly, is not about to go away. However, the therapeutic achievements are still quite modest.

Posts pagination

Newer posts 1 … 4 5 6 7 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×